However, many studies have indicated that tumor cells exposed to hypoxia are resistant to TRAIL-induced cancer cell apoptosis [14,26,27] and overcoming inhibition by hypoxia has been a target in solid tumor anticancer therapy using the TRAIL protein [28,29]. Here, TNFSF10 is linked to neoplasm.